A study of 333 thousand people found that stopping Ozempic erases its cardiovascular benefits far faster than anyone expected. Two years off the drug raises heart risk by 22%.
Approximately one in eight American adults now takes a GLP-1 drug. Most of them start because of weight or blood sugar. Many of them eventually stop, because of cost, side effects, or because they feel they have reached their goal.